ES459230A1 - Esters of testo-sterone and 5 -dihydro-testosterone - Google Patents

Esters of testo-sterone and 5 -dihydro-testosterone

Info

Publication number
ES459230A1
ES459230A1 ES459230A ES459230A ES459230A1 ES 459230 A1 ES459230 A1 ES 459230A1 ES 459230 A ES459230 A ES 459230A ES 459230 A ES459230 A ES 459230A ES 459230 A1 ES459230 A1 ES 459230A1
Authority
ES
Spain
Prior art keywords
esters
alcoholic
sterone
testo
testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES459230A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/691,103 external-priority patent/US4098802A/en
Application filed by Akzo NV filed Critical Akzo NV
Publication of ES459230A1 publication Critical patent/ES459230A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Abstract

Procedure for the preparation of new 17 beta-esters of testoterone and 5 alpha-dihydrotestosterone, characterized in that the steroid alcohol is reacted with an aliphatic monocarboxylic acid having 8-16 carbon atoms or a functional derivative thereof, said acid having the formula in which n = 0 or 1; R1 = alcohol (1-5); and R2 = alcoholic (3-10 C), with the proviso that R2 is not alcoholic (3-6 C), when R1 = alcoholic (1-2 C), *** See image (Machine-translation by Google Translate, not legally binding)
ES459230A 1976-05-28 1977-05-27 Esters of testo-sterone and 5 -dihydro-testosterone Expired ES459230A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/691,103 US4098802A (en) 1975-02-18 1976-05-28 Oral pharmaceutical preparation having androgenic activity

Publications (1)

Publication Number Publication Date
ES459230A1 true ES459230A1 (en) 1978-11-16

Family

ID=24775172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES459230A Expired ES459230A1 (en) 1976-05-28 1977-05-27 Esters of testo-sterone and 5 -dihydro-testosterone

Country Status (12)

Country Link
JP (1) JPS52148060A (en)
AR (1) AR214323A1 (en)
BE (1) BE855163A (en)
CH (1) CH627761A5 (en)
DE (1) DE2723876C2 (en)
DK (1) DK146096C (en)
ES (1) ES459230A1 (en)
FI (1) FI57597C (en)
FR (1) FR2352832A1 (en)
GB (1) GB1567515A (en)
NL (1) NL7705790A (en)
SE (1) SE425493B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1313511T3 (en) * 2000-08-23 2006-03-20 Akzo Nobel Nv Testosterone ester formulation for human use
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت method and pharmaceutical compositions for reliable achievements of acceptable serum testosterone levels
GB0807605D0 (en) * 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
TW201521731A (en) * 2013-03-15 2015-06-16 利波辛股份有限公司 Lipobalanced long chain testosterone esters for oral delivery
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189235C (en) * 1974-02-28 1993-02-16 Akzo Nv METHOD FOR THE PREPARATION OF AN ORAL PHARMACEUTICAL PREPARATION WITH ANDROGENIC ACTION

Also Published As

Publication number Publication date
DE2723876A1 (en) 1977-12-15
FI771684A (en) 1977-11-29
JPS52148060A (en) 1977-12-08
DK146096C (en) 1983-11-21
BE855163A (en) 1977-11-28
AR214323A1 (en) 1979-05-31
SE425493B (en) 1982-10-04
JPS6145637B2 (en) 1986-10-08
GB1567515A (en) 1980-05-14
FR2352832A1 (en) 1977-12-23
SE7706235L (en) 1977-11-29
DE2723876C2 (en) 1986-10-30
FR2352832B1 (en) 1980-07-11
CH627761A5 (en) 1982-01-29
FI57597C (en) 1980-09-10
DK236877A (en) 1977-11-29
FI57597B (en) 1980-05-30
NL7705790A (en) 1977-11-30
DK146096B (en) 1983-06-27

Similar Documents

Publication Publication Date Title
ES459230A1 (en) Esters of testo-sterone and 5 -dihydro-testosterone
ES369570A1 (en) New thiadiazolyl-ureas, their production and composition containing same
ES451979A1 (en) Phenylethanolamine derivatives
ES462662A1 (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
ES454086A1 (en) Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -norosimorphone new. (Machine-translation by Google Translate, not legally binding)
ES478126A1 (en) Compounds of the pregnane series with an oxygen function in the 19-position, processes for their manufacture and pharmaceutical preparations containing these compounds
ES428213A1 (en) Dialkylaminoalkyl esters of penicillin and process for the preparation thereof
ES434484A1 (en) Nitrofuran hydrazones processes for their preparation and pharmaceutical compositions
ES410934A1 (en) Indole-carboxylic acid derivatives
ES402639A1 (en) Tropanol esters of alpha-phenyl-alpha-cyclopentyl-acetic acid
ES396221A1 (en) Phosphorus-containing unsaturated carboxylic acid derivatives
ES395599A1 (en) Orally administered contrast agents for cholecystography
ES390874A1 (en) A procedure for the preparation of chromenol substituted derivatives. (Machine-translation by Google Translate, not legally binding)
ES406542A1 (en) Derivatives of 22-fluoro-digoxins
ES459871A1 (en) Salts of aliphatic-thioethylamines
ES446239A1 (en) 8-azaprostaglandins and process for the preparation thereof
ES458893A1 (en) Pharmaceutical spasmolytic composition
ES393800A1 (en) Penicillin 1-oxides
ES288028A1 (en) Procedure for the obtaining of new derivatives of isotiazol (Machine-translation by Google Translate, not legally binding)
ES233995A1 (en) Procedure for obtaining new esters and their salts (Machine-translation by Google Translate, not legally binding)
ES458836A1 (en) Procedure to prepare new 17 beta-estradiol esters. (Machine-translation by Google Translate, not legally binding)
ES450472A1 (en) Benzoyl pyrazole 5-acetic acid derivatives useful as uricosurucs
ES265558A1 (en) Procedure for the preparation of 1-methyl-string derivatives (Machine-translation by Google Translate, not legally binding)
ES391431A1 (en) A procedure for the preparation of an N-phenyl carbamate compound. (Machine-translation by Google Translate, not legally binding)
ES391604A1 (en) Procedure for the preparation of amidas derived from the steres of piperazin-1 propionic acid. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103